메뉴 건너뛰기




Volumn 6, Issue 226, 2014, Pages

Longitudinal change in CSF biomarkers in autosomal-dominant Alzheimer's disease

(21)  Fagan, Anne M a   Xiong, Chengjie a   Jasielec, Mateusz S a   Bateman, Randall J a   Goate, Alison M a   Benzinger, Tammie L S a,b   Ghetti, Bernardino c   Martins, Ralph N d   Masters, Colin L e   Mayeux, Richard f   Ringman, John M g   Rossor, Martin N h   Salloway, Stephen i   Schofield, Peter R j,k   Sperling, Reisa A l   Marcus, Daniel a,b   Cairns, Nigel J a   Buckles, Virginia D a   Ladenson, Jack H a   Morris, John C a   more..


Author keywords

[No Author keywords available]

Indexed keywords

AMYLOID BETA PROTEIN[1-42]; APOLIPOPROTEIN E; BIOLOGICAL MARKER; TAU PROTEIN; UNCLASSIFIED DRUG; VISININ LIKE PROTEIN 1;

EID: 84897505354     PISSN: 19466234     EISSN: 19466242     Source Type: Journal    
DOI: 10.1126/scitranslmed.3007901     Document Type: Article
Times cited : (317)

References (104)
  • 1
    • 84859052757 scopus 로고    scopus 로고
    • Accuracy of the clinical diagnosis of Alzheimer disease at National Institute on Aging Alzheimer Disease Centers, 2005-2010
    • T. Beach, S. Monsell, L. Phillips, W. Kukull, Accuracy of the clinical diagnosis of Alzheimer disease at National Institute on Aging Alzheimer Disease Centers, 2005-2010. J. Neuropathol. Exp. Neurol. 71, 266-273 (2012).
    • (2012) J. Neuropathol. Exp. Neurol. , vol.71 , pp. 266-273
    • Beach, T.1    Monsell, S.2    Phillips, L.3    Kukull, W.4
  • 2
    • 0030805991 scopus 로고    scopus 로고
    • Frequency of stages of Alzheimer-related lesions in different age categories
    • H. Braak, E. Braak, Frequency of stages of Alzheimer-related lesions in different age categories. Neurobiol. Aging 18, 351-357 (1997).
    • (1997) Neurobiol. Aging , vol.18 , pp. 351-357
    • Braak, H.1    Braak, E.2
  • 3
    • 0029979798 scopus 로고    scopus 로고
    • Profound loss of layer II entorhinal cortex neurons occurs in very mild Alzheimer's disease
    • T. Gómez-Isla, J. Price, D. McKeel, J. Morris, J. Growdon, B. Hyman, Profound loss of layer II entorhinal cortex neurons occurs in very mild Alzheimer's disease. J. Neurosci. 16, 4491-4500 (1996).
    • (1996) J. Neurosci. , vol.16 , pp. 4491-4500
    • Gómez-Isla, T.1    Price, J.2    McKeel, D.3    Morris, J.4    Growdon, J.5    Hyman, B.6
  • 4
    • 0031593785 scopus 로고    scopus 로고
    • Neuropathological and neuropsychological changes in "normal" aging: Evidence for preclinical Alzheimer disease in cognitively normal individuals
    • C. M. Hulette, K. A. Welsh-Bohmer, M. G. Murray, A. M. Saunders, D. C. Mash, L. M. McIntyre, Neuropathological and neuropsychological changes in "normal" aging: Evidence for preclinical Alzheimer disease in cognitively normal individuals. J. Neuropathol. Exp. Neurol. 57, 1168-1174 (1998).
    • (1998) J. Neuropathol. Exp. Neurol. , vol.57 , pp. 1168-1174
    • Hulette, C.M.1    Welsh-Bohmer, K.A.2    Murray, M.G.3    Saunders, A.M.4    Mash, D.C.5    McIntyre, L.M.6
  • 6
    • 0035168927 scopus 로고    scopus 로고
    • Pathologic correlates of nondemented aging, mild cognitive impairment, and early-stage Alzheimer's disease
    • J. Morris, J. Price, Pathologic correlates of nondemented aging, mild cognitive impairment, and early-stage Alzheimer's disease. J. Mol. Neurosci. 17, 101-118 (2001).
    • (2001) J. Mol. Neurosci. , vol.17 , pp. 101-118
    • Morris, J.1    Price, J.2
  • 7
    • 0034849725 scopus 로고    scopus 로고
    • Neuron number in the entorhinal cortex and CA1 in preclinical Alzheimer's disease
    • J. Price, A. Ko, M. Wade, S. Tsou, D. McKeel, J. Morris, Neuron number in the entorhinal cortex and CA1 in preclinical Alzheimer's disease. Arch. Neurol. 58, 1395-1402 (2001).
    • (2001) Arch. Neurol. , vol.58 , pp. 1395-1402
    • Price, J.1    Ko, A.2    Wade, M.3    Tsou, S.4    McKeel, D.5    Morris, J.6
  • 8
    • 70350061949 scopus 로고    scopus 로고
    • Multimodal techniques for diagnosis and prognosis of Alzheimer's disease
    • R. Perrin, A. Fagan, D. Holtzman, Multimodal techniques for diagnosis and prognosis of Alzheimer's disease. Nature 461, 916-922 (2009).
    • (2009) Nature , vol.461 , pp. 916-922
    • Perrin, R.1    Fagan, A.2    Holtzman, D.3
  • 14
    • 62449262536 scopus 로고    scopus 로고
    • Cerebrospinal fluid β-amyloid 42 and tau proteins as biomarkers of Alzheimer-type pathologic changes in the brain
    • T. Tapiola, I. Alafuzoff, S. Herukka, L. Parkkinen, P. Hartikainen, H. Soininen, T. Pirttilä, Cerebrospinal fluid β-amyloid 42 and tau proteins as biomarkers of Alzheimer-type pathologic changes in the brain. Arch. Neurol. 66, 382-389 (2009).
    • (2009) Arch. Neurol. , vol.66 , pp. 382-389
    • Tapiola, T.1    Alafuzoff, I.2    Herukka, S.3    Parkkinen, L.4    Hartikainen, P.5    Soininen, H.6    Pirttilä, T.7
  • 16
    • 0037465449 scopus 로고    scopus 로고
    • CSF Aβ 42 levels correlate with amyloidneuropathology in a population-based autopsy study
    • D. Strozyk, K. Blennow, L. White, L. Launer, CSF Aβ 42 levels correlate with amyloidneuropathology in a population-based autopsy study. Neurology 60, 652-656 (2003).
    • (2003) Neurology , vol.60 , pp. 652-656
    • Strozyk, D.1    Blennow, K.2    White, L.3    Launer, L.4
  • 18
    • 84868114377 scopus 로고    scopus 로고
    • Alzheimer's Disease Neuroimaging Initiative, Visual ratings of atrophy in MCI: Prediction of conversion and relationship with CSF biomarkers
    • M. Lehmann, E. Koedam, J. Barnes, J. Bartlett, F. Barkhof, M. Wattjes, J. Schott, P. Scheltens, N. Fox; Alzheimer's Disease Neuroimaging Initiative, Visual ratings of atrophy in MCI: Prediction of conversion and relationship with CSF biomarkers. Neurobiol. Aging 34, 73-82 (2013).
    • (2013) Neurobiol. Aging , vol.34 , pp. 73-82
    • Lehmann, M.1    Koedam, E.2    Barnes, J.3    Bartlett, J.4    Barkhof, F.5    Wattjes, M.6    Schott, J.7    Scheltens, P.8    Fox, N.9
  • 27
    • 78149330220 scopus 로고    scopus 로고
    • Biomarkers in Alzheimer's disease drug development
    • K. Blennow, Biomarkers in Alzheimer's disease drug development. Nat. Med. 16, 1218-1222 (2010).
    • (2010) Nat. Med. , vol.16 , pp. 1218-1222
    • Blennow, K.1
  • 32
    • 0020333131 scopus 로고
    • Random-effects models for longitudinal data
    • N. Laird, J. Ware, Random-effects models for longitudinal data. Biometrics 38, 963-974 (1982).
    • (1982) Biometrics , vol.38 , pp. 963-974
    • Laird, N.1    Ware, J.2
  • 33
    • 84891481919 scopus 로고    scopus 로고
    • Clinical and psychological characteristics of the initial cohort of the Dominantly Inherited Alzheimer Network (DIAN)
    • M. Storandt, D. Balota, A. Aschenbrenner, J. Morris, Clinical and psychological characteristics of the initial cohort of the Dominantly Inherited Alzheimer Network (DIAN). Neuropsychology 28, 19-29 (2014).
    • (2014) Neuropsychology , vol.28 , pp. 19-29
    • Storandt, M.1    Balota, D.2    Aschenbrenner, A.3    Morris, J.4
  • 43
    • 1342344129 scopus 로고    scopus 로고
    • Clinical, pathological, and biochemical spectrum of Alzheimer disease associated with PS-1 mutations
    • A. Lleó, O. Berezovska, J. Growdon, B. Hyman, Clinical, pathological, and biochemical spectrum of Alzheimer disease associated with PS-1 mutations. Am. J. Geriatr. Psychiatry 12, 146-156 (2004).
    • (2004) Am. J. Geriatr. Psychiatry , vol.12 , pp. 146-156
    • Lleó, A.1    Berezovska, O.2    Growdon, J.3    Hyman, B.4
  • 49
    • 0035836622 scopus 로고    scopus 로고
    • ZCSF tau and Aβ42 levels in patients with Down's syndrome
    • T. Tapiola, H. Soininen, T. Pirttilä, ZCSF tau and Aβ42 levels in patients with Down's syndrome. Neurology 56, 979-980 (2001).
    • (2001) Neurology , vol.56 , pp. 979-980
    • Tapiola, T.1    Soininen, H.2    Pirttilä, T.3
  • 51
    • 77949423619 scopus 로고    scopus 로고
    • Cerebrospinal fluid and plasma biomarkers in Alzheimer's disease
    • K. Blennow, H. Hampel, M. Weiner, H. Zetterberg, Cerebrospinal fluid and plasma biomarkers in Alzheimer's disease. Nat. Rev. Neurol. 6, 131-144 (2010).
    • (2010) Nat. Rev. Neurol. , vol.6 , pp. 131-144
    • Blennow, K.1    Hampel, H.2    Weiner, M.3    Zetterberg, H.4
  • 52
    • 79952793175 scopus 로고    scopus 로고
    • Amyloid β (Aβ) and phospho-tau (p-tau) as diagnostic biomarkers in Alzheimer's disease
    • D. Prvulovic, H. Hampel, Amyloid β (Aβ) and phospho-tau (p-tau) as diagnostic biomarkers in Alzheimer's disease. Clin. Chem. Lab. Med. 49, 367-374 (2011).
    • (2011) Clin. Chem. Lab. Med. , vol.49 , pp. 367-374
    • Prvulovic, D.1    Hampel, H.2
  • 57
    • 84860832253 scopus 로고    scopus 로고
    • CSF VILIP-1 predicts rates of cognitive decline in early Alzheimer disease
    • R. Tarawneh, J. Lee, J. Ladenson, J. Morris, D. Holtzman, CSF VILIP-1 predicts rates of cognitive decline in early Alzheimer disease. Neurology 10, 709-719 (2012).
    • (2012) Neurology , vol.10 , pp. 709-719
    • Tarawneh, R.1    Lee, J.2    Ladenson, J.3    Morris, J.4    Holtzman, D.5
  • 60
    • 77955474927 scopus 로고    scopus 로고
    • Alzheimer's Disease Neuroimaging Initiative, The Alzheimer's Disease Neuroimaging Initiative: Annual change in biomarkers and clinical outcomes
    • L. A. Beckett, D. J. Harvey, A. Gamst, M. Donohue, J. Kornak, H. Zhang, J. H. Kuo; Alzheimer's Disease Neuroimaging Initiative, The Alzheimer's Disease Neuroimaging Initiative: Annual change in biomarkers and clinical outcomes. Alzheimers Dement. 6, 257-264 (2010).
    • (2010) Alzheimers Dement. , vol.6 , pp. 257-264
    • Beckett, L.A.1    Harvey, D.J.2    Gamst, A.3    Donohue, M.4    Kornak, J.5    Zhang, H.6    Kuo, J.H.7
  • 61
    • 76149101242 scopus 로고    scopus 로고
    • Correlation of longitudinal cerebrospinal fluid biomarkers with cognitive decline in healthy older adults
    • E. Stomrud, O. Hansson, H. Zetterberg, K. Blennow, L. Minthon, E. Londos, Correlation of longitudinal cerebrospinal fluid biomarkers with cognitive decline in healthy older adults. Arch. Neurol. 67, 217-223 (2010).
    • (2010) Arch. Neurol. , vol.67 , pp. 217-223
    • Stomrud, E.1    Hansson, O.2    Zetterberg, H.3    Blennow, K.4    Minthon, L.5    Londos, E.6
  • 63
    • 0030599039 scopus 로고    scopus 로고
    • Increasing cerebrospinal fluid tau levels in a subgroup of Alzheimer patients with apolipoprotein E allele ε4 during 14 months follow-up
    • M. Blomberg, M. Jensen, H. Basun, L. Lannfelt, L. Wahlund, Increasing cerebrospinal fluid tau levels in a subgroup of Alzheimer patients with apolipoprotein E allele ε4 during 14 months follow-up. Neurosci. Lett. 214, 163-166 (1996).
    • (1996) Neurosci. Lett. , vol.214 , pp. 163-166
    • Blomberg, M.1    Jensen, M.2    Basun, H.3    Lannfelt, L.4    Wahlund, L.5
  • 66
    • 0033953722 scopus 로고    scopus 로고
    • Three-year follow-up of cerebrospinal fluid tau, β-amyloid 42 and 40 concentrations in Alzheimer's disease
    • T. Tapiola, T. Pirttilä, M. Mikkonen, P. Mehta, I. Alafuzoff, K. Koivisto, H. Soininen, Three-year follow-up of cerebrospinal fluid tau, β-amyloid 42 and 40 concentrations in Alzheimer's disease. Neurosci. Lett. 280, 119-122 (2000).
    • (2000) Neurosci. Lett. , vol.280 , pp. 119-122
    • Tapiola, T.1    Pirttilä, T.2    Mikkonen, M.3    Mehta, P.4    Alafuzoff, I.5    Koivisto, K.6    Soininen, H.7
  • 68
    • 84888201046 scopus 로고    scopus 로고
    • Longitudinal change in CSF tau and Aβ biomarkers for up to 48 months in ADNI
    • J. Toledo, S. Xie, T. Trojanowski, L. Shaw, Longitudinal change in CSF tau and Aβ biomarkers for up to 48 months in ADNI. Acta Neuropathol. 126, 659-670 (2013).
    • (2013) Acta Neuropathol. , vol.126 , pp. 659-670
    • Toledo, J.1    Xie, S.2    Trojanowski, T.3    Shaw, L.4
  • 70
    • 79959676662 scopus 로고    scopus 로고
    • Longitudinal change in CSF biomarkers in a presymptomatic carrier of an APP mutation
    • J. Ringman, K. Taylor, E. Teng, G. Coppola, K. Gylys, Longitudinal change in CSF biomarkers in a presymptomatic carrier of an APP mutation. Neurology 76, 2124-2125 (2011).
    • (2011) Neurology , vol.76 , pp. 2124-2125
    • Ringman, J.1    Taylor, K.2    Teng, E.3    Coppola, G.4    Gylys, K.5
  • 72
    • 0027749448 scopus 로고
    • The Consortium to Establish a Registry for Alzheimer's Disease (CERAD). Part IV. Rates of cognitive change in the longitudinal assessment of probable Alzheimer's disease
    • J. Morris, S. Edland, C. Clark, D. Galasko, E. Koss, R. Mohs, G. Van Belle, G. Fillenbaum, A. Heyman, The Consortium to Establish a Registry for Alzheimer's Disease (CERAD). Part IV. Rates of cognitive change in the longitudinal assessment of probable Alzheimer's disease. Neurology 43, 2457-2465 (1993).
    • (1993) Neurology , vol.43 , pp. 2457-2465
    • Morris, J.1    Edland, S.2    Clark, C.3    Galasko, D.4    Koss, E.5    Mohs, R.6    Van Belle, G.7    Fillenbaum, G.8    Heyman, A.9
  • 74
    • 80155148102 scopus 로고    scopus 로고
    • Dynamic analysis of amyloid β-protein in behaving mice reveals opposing changes in ISF versus parenchymal Aβ during age-related plaque formation
    • S. Hong, O. Quintero-Monzon, B. Ostaszewski, D. Podlisny, W. Cavanaugh, T. Yang, D. Holtzman, J. Cirrito, D. Selkoe, Dynamic analysis of amyloid β-protein in behaving mice reveals opposing changes in ISF versus parenchymal Aβ during age-related plaque formation. J. Neurosci. 31, 15861-15869 (2011).
    • (2011) J. Neurosci. , vol.31 , pp. 15861-15869
    • Hong, S.1    Quintero-Monzon, O.2    Ostaszewski, B.3    Podlisny, D.4    Cavanaugh, W.5    Yang, T.6    Holtzman, D.7    Cirrito, J.8    Selkoe, D.9
  • 77
    • 0141751616 scopus 로고    scopus 로고
    • Change in rates of cerebral atrophy over time in early-onset Alzheimer's disease: Longitudinal MRI study
    • D. Chan, J. Janssen, J. Whitwell, H. Watt, R. Jenkins, C. Frost, M. Rossor, N. Fox, Change in rates of cerebral atrophy over time in early-onset Alzheimer's disease: Longitudinal MRI study. Lancet 362, 1121-1122 (2003).
    • (2003) Lancet , vol.362 , pp. 1121-1122
    • Chan, D.1    Janssen, J.2    Whitwell, J.3    Watt, H.4    Jenkins, R.5    Frost, C.6    Rossor, M.7    Fox, N.8
  • 80
    • 80051562627 scopus 로고    scopus 로고
    • Acceleration of cortical thinning in familial Alzheimer's disease
    • W. Knight, L. Kim, A. Douiri, C. Frost, M. Rossor, N. Fox, Acceleration of cortical thinning in familial Alzheimer's disease. Neurobiol. Aging 32, 1765-1773 (2011).
    • (2011) Neurobiol. Aging , vol.32 , pp. 1765-1773
    • Knight, W.1    Kim, L.2    Douiri, A.3    Frost, C.4    Rossor, M.5    Fox, N.6
  • 82
    • 0023944331 scopus 로고
    • Validation of clinical diagnostic criteria for Alzheimer's disease
    • J. Morris, D. McKeel, K. Fulling, R. Torack, L. Berg, Validation of clinical diagnostic criteria for Alzheimer's disease. Ann. Neurol. 24, 17-22 (1988).
    • (1988) Ann. Neurol. , vol.24 , pp. 17-22
    • Morris, J.1    McKeel, D.2    Fulling, K.3    Torack, R.4    Berg, L.5
  • 83
    • 0027425211 scopus 로고
    • The Clinical Dementia Rating (CDR): Current version and scoring rules
    • J. C. Morris, The Clinical Dementia Rating (CDR): Current version and scoring rules. Neurology 43, 2412-2414 (1993).
    • (1993) Neurology , vol.43 , pp. 2412-2414
    • Morris, J.C.1
  • 85
    • 0021271971 scopus 로고
    • Clinical diagnosis of Alzheimer's disease: Report of the NINCDS-ADRDA Work Group under the auspices of Department of Health and Human Services Task Force on Alzheimer's Disease
    • G. McKhann, D. Drachman, M. Folstein, R. Katzman, D. Price, E. Stadlan, Clinical diagnosis of Alzheimer's disease: Report of the NINCDS-ADRDA Work Group under the auspices of Department of Health and Human Services Task Force on Alzheimer's Disease. Neurology 34, 939-944 (1984).
    • (1984) Neurology , vol.34 , pp. 939-944
    • McKhann, G.1    Drachman, D.2    Folstein, M.3    Katzman, R.4    Price, D.5    Stadlan, E.6
  • 88
    • 34249949113 scopus 로고    scopus 로고
    • Extreme cerebrospinal fluid amyloid β levels identify family with late-onset Alzheimer's disease presenilin 1 mutation
    • J. Kauwe, S. Jacquart, S. Chakraverty, J. Wang, K. Mayo, A. Fagan, D. Holtzman, J. Morris, A. Goate, Extreme cerebrospinal fluid amyloid β levels identify family with late-onset Alzheimer's disease presenilin 1 mutation. Ann. Neurol. 61, 446-453 (2007).
    • (2007) Ann. Neurol. , vol.61 , pp. 446-453
    • Kauwe, J.1    Jacquart, S.2    Chakraverty, S.3    Wang, J.4    Mayo, K.5    Fagan, A.6    Holtzman, D.7    Morris, J.8    Goate, A.9
  • 92
    • 33947223454 scopus 로고    scopus 로고
    • Cerebrospinal fluid tau/β-amyloid42 ratio as a prediction of cognitive decline in nondemented older adults
    • A. Fagan, C. Roe, C. Xiong, M. Mintun, J. Morris, D. Holtzman, Cerebrospinal fluid tau/β-amyloid42 ratio as a prediction of cognitive decline in nondemented older adults. Arch. Neurol. 64, 343-349 (2007).
    • (2007) Arch. Neurol. , vol.64 , pp. 343-349
    • Fagan, A.1    Roe, C.2    Xiong, C.3    Mintun, M.4    Morris, J.5    Holtzman, D.6
  • 99
    • 0031955835 scopus 로고    scopus 로고
    • Correction for partial volume effects in PET: Principle and validation
    • O. G. Rousset, Y. Ma, A. C. Evans, Correction for partial volume effects in PET: Principle and validation. J. Nuclear Med. 39, 904-911 (1998).
    • (1998) J. Nuclear Med. , vol.39 , pp. 904-911
    • Rousset, O.G.1    Ma, Y.2    Evans, A.C.3
  • 100
    • 0001138328 scopus 로고
    • Algorithm AS 136: A K-means clustering algorithm
    • J. Hartigan, M. Wong, Algorithm AS 136: A K-means clustering algorithm. J. R. Stat. Soc. Ser. C 28, 100-108 (1979).
    • (1979) J. R. Stat. Soc. Ser. C , vol.28 , pp. 100-108
    • Hartigan, J.1    Wong, M.2
  • 103
    • 0002552781 scopus 로고
    • S, J. Chambers, T. Hastie, Eds. Chapman and Hall, New York
    • W. Cleveland, E. Grosse, W. Shyu, in Statistical Models in S, J. Chambers, T. Hastie, Eds. (Chapman and Hall, New York, 1992), pp. 309-376.
    • (1992) Statistical Models , pp. 309-376
    • Cleveland, W.1    Grosse, E.2    Shyu, W.3
  • 104
    • 0030880605 scopus 로고    scopus 로고
    • Small sample inference for fixed effects from restricted maximum likelihood
    • M. Kenward, J. Roger, Small sample inference for fixed effects from restricted maximum likelihood. Biometrics 53, 983-997 (1997).
    • (1997) Biometrics , vol.53 , pp. 983-997
    • Kenward, M.1    Roger, J.2


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.